|
gptkbp:instance_of
|
gptkb:Ophthalmology
|
|
gptkbp:administered_by
|
gptkb:cream
|
|
gptkbp:approves
|
gptkb:1991
gptkb:FDA
|
|
gptkbp:available_on
|
suspension
ointment
|
|
gptkbp:category
|
gptkb:C
|
|
gptkbp:clinical_trial
|
Phase 3
|
|
gptkbp:clinical_use
|
short-term treatment
adjunctive therapy
|
|
gptkbp:community_service
|
yes
|
|
gptkbp:contains
|
gptkb:dexamethasone
gptkb:tobramycin
|
|
gptkbp:contraindication
|
hypersensitivity to components
fungal eye infections
viral eye infections
|
|
gptkbp:counseling_services
|
shake well before use
do not touch dropper tip
discard after 28 days of opening
|
|
gptkbp:dosage_form
|
topical solution
ointment
|
|
gptkbp:duration_of_treatment
|
up to 7 days
|
|
gptkbp:formulation
|
suspension
ointment
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Tobradex
|
|
gptkbp:indication
|
bacterial conjunctivitis
post-operative inflammation
|
|
gptkbp:ingredients
|
gptkb:dexamethasone
gptkb:tobramycin
|
|
gptkbp:interacts_with
|
aminoglycosides
other corticosteroids
|
|
gptkbp:manufacturer
|
gptkb:Alcon
|
|
gptkbp:marketed_as
|
gptkb:Canada
gptkb:European_Union
gptkb:United_States
|
|
gptkbp:packaging
|
gptkb:bottle
tube
|
|
gptkbp:pharmacokinetics
|
topical absorption
antibiotic and anti-inflammatory
|
|
gptkbp:requires
|
gptkb:true
|
|
gptkbp:route_of_administration
|
topical
|
|
gptkbp:shelf_life
|
24 months
|
|
gptkbp:side_effect
|
allergic reaction
eye irritation
burning sensation
eye pain
vision changes
redness of the eye
|
|
gptkbp:storage
|
room temperature
protected from light
|
|
gptkbp:strength
|
0.1% dexamethasone
0.3% tobramycin
|
|
gptkbp:used_for
|
reducing inflammation
treating eye infections
|
|
gptkbp:bfsParent
|
gptkb:Bausch_+_Lomb_Eye_Products_Inc.
gptkb:Valeant_Pharmaceuticals
|
|
gptkbp:bfsLayer
|
6
|